Riskpilot← Back to searchSign inGet full accessCardioMind AB
ABActiveOrg 5569341737Linnés Väg 140Medical specialists activities · NACE 8622Est. 20131 employees
Revenue 2024
SEK 199K
EBITDA margin
72.4%
Equity ratio
69.3%
Financial strength
Net profit 2024
SEK 128K
1 employees
| Revenue | SEK 199K | — |
| EBITDA | SEK 144K | — |
| Net profit | SEK 128K | — |
| Total assets | SEK 313K | — |
| Equity | SEK 217K | — |
| Employees | 1 | — |
Legal name
CardioMind AB
Org number
5569341737
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 juni 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utföra konsultuppdrag inom internmedicin, kardiologi och klinisk fysiologi. Det omfattar läkartjänst, informationsarbete, och föreläsningar. I informationsarbete ingår medicinska och vetenskapliga reportage i olika mediaformer.
Address
Linnés Väg 140
Phone
+46705739607
Email
wei@cardiomind.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 47 | 140 | 229 | — | 199 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 43 | −33 | 27 | 0 | 144 |
| Depreciation & amort. | −0 | −0 | −0 | — | −0 |
| EBIT | 43 | −33 | 27 | 0 | 144 |
| Net financials | 2 | 1 | 1 | — | 2 |
| Profit before tax | 45 | −32 | 27 | 0 | 146 |
| Tax | −0 | −0 | −0 | — | −18 |
| Net profit | 45 | −32 | 27 | — | 128 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 364 | 198 | 229 | — | 313 |
| Equity | 267 | 115 | 143 | — | 217 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 97 | 83 | 86 | — | 96 |
| Total debt | 97 | 83 | 86 | — | 96 |
EBITDA margin
72.4%
This company
15.8%
Market median
+358% vs market
20202024
Equity ratio
69.3%
This company
38.2%
Market median
+81% vs market
20202024
Return on equity
59.0%
This company
18.4%
Market median
+221% vs market
20202024
Net profit margin
64.3%
This company
8.1%
Market median
+694% vs market
20202024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20202024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
WY Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
ES Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CardioMind AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Wei Yu | Chief Executive Officer | 0 companies |
| Erik Stefan Hägglund | Deputy Chief Executive Officer | 0 companies |
| Agnes Simone Hägglund | Deputy Board Member | 0 companies |
| Gloria Hao | Deputy Board Member | 0 companies |